• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

More isn’t better when it comes to evaluating chest pain

Bioengineer by Bioengineer
May 29, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Study shows that extensive testing doesn’t help predict major cardiac events

IMAGE

Credit: UC Regents / UC Davis Health

Most patients seen in a hospital emergency department for chest pain did not experience major cardiac events within six months following discharge, new research from UC Davis Health and Oregon Health Sciences University cardiologists shows.

Also, the few study participants who had major cardiac events within six months of discharge were not identified by cardiac testing they received while in the hospital.

Published in the June 2019 issue of the American Journal of Cardiology, the results confirm growing evidence that advanced cardiac tests for chest pain should not be routine but performed only when initial assessments indicate heart disease is likely. They also point to the need for new tools to more accurately predict the possibility of a major cardiac event.

Reason for alarm, but not always additional tests

“Chest pain should always be a cause for alarm and initiate a rapid medical response to determine if it is a symptom of blocked artery or heart attack,” said senior author Ezra Amsterdam, professor of cardiovascular medicine at UC Davis Health.

That response, Amsterdam added, should include a complete medical history focused on common heart disease risks such as tobacco use, high blood pressure and diabetes; one or more electrocardiograms to assess for evidence of heart damage or decreased cardiac blood flow; and one or two troponin tests to identify cardiac muscle injury.

“If all indications at that point are negative, there is usually little reason to administer additional tests such as cardiac nuclear scans, stress tests and angiograms, which increase time in the hospital and costs and pose additional risk without increasing diagnostic value,” Amsterdam said.

A unique look at post-discharge outcomes

Amsterdam is an expert in the diagnosis and management of chest pain, the second most frequent cause of emergency department visits in the U.S. He and his colleagues launched the Chest Pain Unit (CPU) in the UC Davis Medical Center Emergency Department nearly three decades ago to speed assessments of patients with chest pain as their primary symptom.

For the study, records of 619 CPU patients were reviewed for initial and advanced tests they received in the hospital. Post-discharge information was available for about two-thirds of the patients and evaluated to determine if any of them experienced a major cardiac event — heart attack, cardiac arrest or heart bypass procedure.

At 30 days, none had experienced a cardiac event. At six months, four had experienced major cardiac events: two received advanced cardiac testing while in the hospital and two did not. Of the two who did not, one experienced a fatal heart attack.

Striving for 100% prediction of major cardiac events

Amsterdam said there are highly sensitive methods currently being investigated to predict major cardiac events, including noninvasive imaging, blood tests and patient risk scores. Combined with a clinical history and exam, these evaluations could help better determine who should and should not get advanced cardiac testing.

“We have gotten so much better at identifying high-risk groups for major cardiac events, however we haven’t gotten to the point where we can do so 100% of the time,” Amsterdam said. “That is the goal, but we just aren’t there yet with currently available tests.”

###

Amsterdam’s coauthors were Pooja Prasad, Navya Vipparla and Sandya Venugopal of UC Davis Health, and lead author Stacey Howell of Oregon Health Sciences University. Their work received no external funding.

A copy of the study, “Usefulness of Predischarge Cardiac Testing in Low Risk Women and Men for Safe, Rapid Discharge from a Chest Pain Unit,” is available on the journal’s website.

Cardiovascular medicine specialists and subspecialists at UC Davis Health are passionate about providing the highest level of care for all patients with heart disease. The team includes nationally recognized experts in minimally invasive methods for diagnosing and treating coronary artery disease, valve disease and arrhythmias. UC Davis cardiologists are exceptional clinicians in addition to leaders in testing next-generation therapies, technologies and procedures that improve outcomes for patients worldwide. For more information, visit the Division of Cardiovascular Medicine website.

Media Contact
Karen Finney
[email protected]

Original Source

https://health.ucdavis.edu/publish/news/contenthub/13878

Related Journal Article

http://dx.doi.org/10.1016/j.amjcard.2019.02.039

Tags: CardiologyCritical Care/Emergency MedicineHealth CareInternal MedicineMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Balancing Energy and Stability in Gait Navigation

September 8, 2025

Transitioning Schizophrenia Patients to TV-46000 Antipsychotic

September 8, 2025

Network Analysis Links Emotion Dysregulation to Eating Disorders

September 8, 2025

New Blood Test Promises to Streamline Early Detection of Alzheimer’s Disease

September 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Balancing Energy and Stability in Gait Navigation

Path to Widespread Use of Frugal Microscopes

Transitioning Schizophrenia Patients to TV-46000 Antipsychotic

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.